Last reviewed · How we verify

NCT04142307

Biofeedback in Idiopathic Infantile Nystagmus Syndrome

Recruiting now NA Last updated 1 May 2025
What this trial tests

NA trial testing Biofeedback Training in Low Vision in Children in 34 participants. Currently enrolling.

Timeline
30 January 2019
Primary endpoint
29 April 2025
30 December 2027

Quick facts

Lead sponsorMonica Daibert Nido
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment34
Start date30 January 2019
Primary completion29 April 2025
Estimated completion30 December 2027
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Monica Daibert Nido

Who can join

Adults 5 to 17, any sex, with Low Vision in Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Active eye movement control training, an old and still most prevalent intervention in low vision rehabilitation (LVR) was never used in nystagmus clinically. Biofeedback training (BT) is the latest and newest technique for oculomotor control training in cases with low vision when using available modules in the new microperimetry instruments. Laboratory studies in the literature highlighted positive benefits from using BT in nystagmus cases. The purpose of this study is to assess systematically the impact of BT in a series of cases with Infantile Idiopathic Nystagmus (IIN) and formulate guidelines for further use of this intervention in nystagmus cases in general.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Post audio-visual biofeedback training visual functions and quality of life in paediatric idiopathic infantile nystagmus: A pilot study.
    Daibert-Nido M, Pyatova Y, Markowitz M, Taheri-Shirazi M, et al · · 2021 · cited 4× · PMID 33499653 · DOI 10.1177/1120672121991048

Verify or expand the search:

Other trials of Biofeedback Training

Trials testing the same drug.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04142307.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing